{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:47:01Z","timestamp":1787237221818,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Diagnosing and treating hypercalcemia during pregnancy can be challenging due to both the physiological changes in calcium homeostasis and the underlying cause for the hypercalcemia. During pregnancy and lactation there is increased mobilization of calcium in the mother to meet the fetus\u2019 calcium requirements. Here we discuss the diagnostic challenges, management, and patient perspective of hypercalcemia during pregnancy in two particular cases and in other rare conditions causing hypercalcemia.<\/jats:p>","DOI":"10.1007\/s12020-021-02615-2","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T08:59:34Z","timestamp":1612515574000},"page":"604-610","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Hypercalcemia during pregnancy: management and outcomes for mother and child"],"prefix":"10.1007","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5035-127X","authenticated-orcid":false,"given":"Natasha M.","family":"Appelman-Dijkstra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana- Alexandra","family":"Ertl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"Zillikens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Rjenmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,5]]},"reference":[{"key":"2615_CR1","doi-asserted-by":"publisher","unstructured":"R. Pal, S. K. Bhadada, N. Gupta, A. Behera, N. Aggarwal, A. Aggarwal, K. V. Raviteja, U. N. Saikia, G. Kaur, S. M. Arvindbhai, R. Walia, Primary hyperparathyroidism in pregnancy: observations from the Indian PHPT registry. J. Endocrinol. Investig. https:\/\/doi.org\/10.1007\/s40618-020-01441-z. Online ahead of print. (2020)","DOI":"10.1007\/s40618-020-01441-z"},{"key":"2615_CR2","first-page":"451","volume":"43","author":"EM Graham","year":"1998","unstructured":"E.M. Graham, L.J. Freedman, I. Forouzan, Intrauterine growth retardation in a woman with primary hyperparathyroidism. A case report. J. Reprod. Med. 43, 451\u2013454 (1998)","journal-title":"J. Reprod. Med."},{"key":"2615_CR3","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.beem.2011.07.001","volume":"25","author":"MS Cooper","year":"2011","unstructured":"M.S. Cooper, Disorders of calcium metabolism and parathyroid disease. Best. Pract. Res. Clin. Endocrinol. Metab. 25, 975\u2013983 (2011)","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"2615_CR4","first-page":"3947423","volume":"2017","author":"Y Hu","year":"2017","unstructured":"Y. Hu, M. Cui, Z. Sun, Z. Su, X. Gao, Q. Liao, Y. Zhao, Clinical presentation, management, and outcomes of primary hyperparathyroidism during pregnancy. Int. J. Endocrinol. 2017, 3947423 (2017)","journal-title":"Int. J. Endocrinol."},{"key":"2615_CR5","first-page":"832","volume":"18","author":"CS Kovacs","year":"1997","unstructured":"C.S. Kovacs, H.M. Kronenberg, Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr. Rev. 18, 832\u2013872 (1997)","journal-title":"Endocr. Rev."},{"key":"2615_CR6","doi-asserted-by":"crossref","unstructured":"E.M. Winter, A. Ireland, N.C. Butterfield, M. Haffner-Luntzer, M.-N. Horcajada, A.G. Veldhuis-Vlug, L. Oei, G. Colaianni, N. Bonnet, Pregnancy and lactation, a challenge for the skeleton. Endocr. Connect. R143\u2013R157 (2020)","DOI":"10.1530\/EC-20-0055"},{"key":"2615_CR7","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1530\/eje.0.1370402","volume":"137","author":"MS Ardawi","year":"1997","unstructured":"M.S. Ardawi, H.A. Nasrat, H.S. BA\u2019Aqueel, Calcium-regulating hormones and parathyroid hormone-related peptide in normal human pregnancy and postpartum: a longitudinal study. Eur. J. Endocrinol. 137, 402\u2013409 (1997)","journal-title":"Eur. J. Endocrinol."},{"key":"2615_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1101\/gad.8.3.277","volume":"8","author":"AC Karaplis","year":"1994","unstructured":"A.C. Karaplis, A. Luz, J. Glowacki, R.T. Bronson, V.L. Tybulewicz, H.M. Kronenberg, R.C. Mulligan, Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev. 8, 277\u2013289 (1994)","journal-title":"Genes Dev."},{"key":"2615_CR9","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1126\/science.273.5275.663","volume":"273","author":"B Lanske","year":"1996","unstructured":"B. Lanske, A.C. Karaplis, K. Lee, A. Luz, A. Vortkamp, A. Pirro, M. Karperien, L.H.K. Defize, C. Ho, R.C. Mulligan, A.B. Abou-Samra, H. Juppner, G.V. Segre, H.M. Kronenberg, PTH\/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 273, 663\u2013666 (1996)","journal-title":"Science"},{"key":"2615_CR10","doi-asserted-by":"publisher","first-page":"4613","DOI":"10.1210\/endo.141.12.7812","volume":"141","author":"RS Goomer","year":"2000","unstructured":"R.S. Goomer, K.A. Johnson, D.W. Burton, D. Amiel, T.M. Maris, A. Gurjal, L.J. Deftost, R. Terkeltaub, The tetrabasic KKKK(147-150) motif determines intracrine regulatory effects of PTHrP 1-173 on chondrocyte PPi metabolism and matrix synthesis. Endocrinology 141, 4613\u20134622 (2000)","journal-title":"Endocrinology"},{"key":"2615_CR11","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1359\/jbmr.2000.15.6.1033","volume":"15","author":"PH Watson","year":"2000","unstructured":"P.H. Watson, L.J. Frahier, G.N. Hendy, U.I. Chung, M. Kisiel, B.W. Natale, A.B. Hodsman, Nuclear localization of the type 1 PTH\/PTHrP receptor in rat tissues. J. Bone Miner. Res. 15, 1033\u20131044 (2000)","journal-title":"J. Bone Miner. Res."},{"key":"2615_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S8756-3282(99)00110-6","volume":"25","author":"H Juppner","year":"1999","unstructured":"H. Juppner, Receptors for parathyroid hormone and parathyroid hormone-related peptide: exploration of their biological importance. Bone 25, 87\u201390 (1999)","journal-title":"Bone"},{"key":"2615_CR13","first-page":"199","volume":"81","author":"M Everhart-Caye","year":"1996","unstructured":"M. Everhart-Caye, S.E. Inzucchi, J. Guinness-Henry, M.A. Mitnick, A.F. Stewart, Parathyroid hormone (PTH)-related protein (1-36) is equipotent to PTH(1-34) in humans. J. Clin. Endocrinol. Metab. 81, 199\u2013208 (1996)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2615_CR14","unstructured":"Kovacs C. S. Calcium and phosphate metabolism and related disorders during pregnancy and lactation. ed. by K.R. Feingold, B. Anawalt, A. Boyce, G. Chrousos, W. W. de Herder, K. Dungan, A. Grossman, J.M. Hershman, H.J. Hofland, G. Kaltsas, C. Koch, P. Kopp, M. Korbonits, R. McLachlan, J.E. Morley, M. New, J. Purnell, F. Singer, C.A. Stratakis, D.L. Trence, D.P. Wilson (Endotext, South Dartmouth Massachusetts, 2018)"},{"key":"2615_CR15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s12020-013-9980-4","volume":"44","author":"G Diaz-Soto","year":"2013","unstructured":"G. Diaz-Soto, A. Linglart, M.V. S\u00e9nat, P. Kamenicky, P. Chanson, Primary hyperparathyroidism in pregnancy. Endocrine 44, 591\u2013597 (2013)","journal-title":"Endocrine"},{"key":"2615_CR16","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.metabol.2011.11.001","volume":"61","author":"MP Hage","year":"2012","unstructured":"M.P. Hage, I. Salti, G. El-Hajj Fuleihan, Parathyromatosis: a rare yet problematic etiology of recurrent and persistent hyperparathyroidism. Metabolism 61, 762\u2013775 (2012)","journal-title":"Metabolism"},{"key":"2615_CR17","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1308\/rcsann.2019.0105","volume":"101","author":"M Haciyanli","year":"2019","unstructured":"M. Haciyanli, S. Karaisli, S. Gucek Haciyanli, A. Atasever, D. Arikan Etit, E.O. Gur, T. Acar, Parathyromatosis: a very rare cause of recurrent primary hyperparathyroidism\u2014case report and review of the literature. Ann. R. Coll. Surg. Engl. 101, e178\u2013e183 (2019)","journal-title":"Ann. R. Coll. Surg. Engl."},{"key":"2615_CR18","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.4158\/EP13105.CR","volume":"20","author":"KL Edling","year":"2014","unstructured":"K.L. Edling, S.G. Korenman, C. Janzen, M.Y. Sohsman, S.K. Apple, S. Bhuta, M.W. Yeh, A pregnant dilemma: primary hyperparathyroidism due to parathyromatosis in pregnancy. Endocr. Pr. 20, e14\u2013e17 (2014)","journal-title":"Endocr. Pr."},{"key":"2615_CR19","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.beem.2018.05.004","volume":"32","author":"JY Lee","year":"2018","unstructured":"J.Y. Lee, D.M. Shoback, Familial hypocalciuric hypercalcemia and related disorders. Best. Pr. Res Clin. Endocrinol. Metab. 32, 609\u2013619 (2018)","journal-title":"Best. Pr. Res Clin. Endocrinol. Metab."},{"key":"2615_CR20","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.beem.2013.04.007","volume":"27","author":"FM Hannan","year":"2013","unstructured":"F.M. Hannan, R.V. Thakker, Calcium-sensing receptor (CaSR) mutations and disorders of calcium, electrolyte and water metabolism. Best. Pract. Res. Clin. Endocrinol. Metab. 27, 359\u2013371 (2013)","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"2615_CR21","doi-asserted-by":"publisher","first-page":"R127","DOI":"10.1530\/JME-16-0124","volume":"57","author":"FM Hannan","year":"2016","unstructured":"F.M. Hannan, V.N. Babinsky, R.V. Thakker, Disorders of the calcium-sensing receptor and partner proteins: insights into the molecular basis of calcium homeostasis. J. Mol. Endocrinol. 57, R127\u2013R142 (2016)","journal-title":"J. Mol. Endocrinol."},{"key":"2615_CR22","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/0092-8674(93)90617-Y","volume":"75","author":"MR Pollak","year":"1993","unstructured":"M.R. Pollak, E.M. Brown, Y.H. Chou et al., Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75, 1297\u20131303 (1993)","journal-title":"Cell"},{"key":"2615_CR23","doi-asserted-by":"crossref","unstructured":"M.A. Nesbit, F.M. Hannan, S.A. Howles, V.N. Babinsky, R.A. Head, T. Cranston, N. Rust, M.R. Hobbs, H. Heath, R.V. Thakker, Mutations affecting G-protein subunit alpha11 in hypercalcemia and hypocalcemia. N. Engl. J. Med. 368, 2476\u20132486 (2013a)","DOI":"10.1056\/NEJMoa1300253"},{"key":"2615_CR24","doi-asserted-by":"crossref","unstructured":"M.A. Nesbit, F.M. Hannan, S.A. Howles, A.A. Reed, T. Cranston, C.E. Thakker, L. Gregory, A.J. Rimmer, N. Rust, U. Graham et al., Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3. Nat. Genet. 45, 93\u201397 (2013b)","DOI":"10.1038\/ng.2492"},{"key":"2615_CR25","first-page":"158","volume":"3","author":"A Walker","year":"2014","unstructured":"A. Walker, J.J. Fraile, J.G. Hubbard, \u201cParathyroidectomy in pregnancy\u201d\u2014a single centre experience with review of evidence and proposal for treatment algorithm. Gland Surg. 3, 158\u2013164 (2014)","journal-title":"Gland Surg."},{"key":"2615_CR26","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1002\/ccr3.1074","volume":"5","author":"G Maltese","year":"2017","unstructured":"G. Maltese, L. Izatt, B.M. McGowan, K. Hafeez, J.G. Hubbard, P.V. Carroll, Making (mis) sense of asymptomatic marked hypercalcemia in pregnancy. Clin. Case Rep. 5, 1587\u20131590 (2017)","journal-title":"Clin. Case Rep."},{"key":"2615_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10362","volume":"4","author":"AR Jones","year":"2020","unstructured":"A.R. Jones, M.J. Hare, J. Brown et al., Familial hypocalciuric hypercalcemia in pregnancy: diagnostic pitfalls. JBMR Plus. 4, e10362 (2020)","journal-title":"JBMR Plus."},{"key":"2615_CR28","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1530\/EJE-11-1050","volume":"166","author":"C Eller-Vainicher","year":"2012","unstructured":"C. Eller-Vainicher, M.W. Ossola, P. Beck-Peccoz, I. Chiodini, PTHrP-associated hypercalcemia of pregnancy resolved after delivery: a case report. Eur. J. Endocrinol. 166, 753\u2013756 (2012)","journal-title":"Eur. J. Endocrinol."},{"key":"2615_CR29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1001\/archsurg.1988.01400250090016","volume":"123","author":"JA Van Heerden","year":"1988","unstructured":"J.A. Van Heerden, H. Gharib, I.T. Jackson, Pseudohyperparathyroidism secondary to gigantic mammary hypertrophy. Arch. Surg. 123, 80\u201382 (1988)","journal-title":"Arch. Surg."},{"key":"2615_CR30","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1507\/endocrj.K08E-092","volume":"55","author":"K Sato","year":"2008","unstructured":"K. Sato, Hypercalcemia during pregnancy, puerperium, and lactation: review and a case report of hypercalcemic crisis after delivery due to excessive production of PTH-related protein (PTHrP) without malignancy (humoral hypercalcemia of pregnancy). Endocr. J. 55, 959\u2013966 (2008)","journal-title":"Endocr. J."},{"key":"2615_CR31","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.1210\/jc.2017-01617","volume":"102","author":"EM Winter","year":"2017","unstructured":"E.M. Winter, N.M. Appelman-Dijkstra, Parathyroid hormone-related protein-induced hypercalcemia of pregnancy successfully reversed by a dopamine agonist. J. Clin. Endocrinol. Metab. 102, 4417\u20134420 (2017)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2615_CR32","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1210\/jc.2018-01181","volume":"103","author":"T Modarressi","year":"2018","unstructured":"T. Modarressi, M.A. Levine, J. Tchou, A.N. Khan, Gestational gigantomastia complicated by PTHrP-mediated hypercalcemia. J. Clin. Endocrinol. Metab. 103, 3124\u20133130 (2018)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2615_CR33","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1447-0756.1999.tb01124.x","volume":"25","author":"T Anai","year":"1999","unstructured":"T. Anai, T. Tomiyasu, K. Arima, I. Miyakawa, Pregnancy-associated osteoporosis with elevated levels of circulating parathyroid hormone-related protein: a report of two cases. J. Obstet. Gynaecol. Res. 25, 63\u201367 (1999)","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"2615_CR34","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.ecl.2011.08.002","volume":"40","author":"CS Kovacs","year":"2011","unstructured":"C.S. Kovacs, Calcium and bone metabolism disorders during pregnancy and lactation. Endocrinol. Metab. Clin. North Am. 40, 795\u2013826 (2011)","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"2615_CR35","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1001\/archinte.1952.00240040026003","volume":"89","author":"TE Fitz","year":"1952","unstructured":"T.E. Fitz, B.L. Hallman, Mental changes associated with primary hyperparathyroidism: report of two cases. AMA Arch. Intern. Med. 89, 547\u2013551 (1952)","journal-title":"AMA Arch. Intern. Med."},{"key":"2615_CR36","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.surg.2006.12.004","volume":"141","author":"C Caillard","year":"2007","unstructured":"C. Caillard, F. Sebag, M. Mathonnet, H. Gibelin, L. Brunaud, C. Loudot, J.L. Kraimps, A. Hamy, L. Bresler, B. Charbonnel, J. Leborgne, J.F. Henry, J.M. Nguyen, E. Mirallie, Prospective evaluation of quality of life (SF-36v2) and nonspecific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up). Surgery 141, 153\u2013159 (2007)","journal-title":"Surgery"},{"key":"2615_CR37","doi-asserted-by":"crossref","unstructured":"G. El-Hajj Fuleihan, E.M. Brown, in Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism, ed. by J.P. Bilezikian, R. Marcus, M.A. Levine, C. Marcocci, S. J. Silverberg, J.T. Potts, The Parathyroids. 3rd ed. (Academic Press, London, 2015), pp. 365\u2013387","DOI":"10.1016\/B978-0-12-397166-1.00024-2"},{"key":"2615_CR38","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1172\/JCI117062","volume":"93","author":"MR Pollak","year":"1994","unstructured":"M.R. Pollak, Y.H. Chou, S.J. Marx, et al. Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype.J. Clin. Investig. 93, 1108\u20131112 (1994)","journal-title":"J. Clin. Investig."},{"key":"2615_CR39","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3109\/00016347509157776","volume":"54","author":"NT Pedersen","year":"1975","unstructured":"N.T. Pedersen, H. Permin, Hyperparathyroidism and pregnancy. Report of a case and review of the literature. Acta. Obstet. Gynecol. Scand. 54, 281\u2013283 (1975)","journal-title":"Acta. Obstet. Gynecol. Scand."},{"key":"2615_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1530\/EJE-13-0966","volume":"171","author":"A Abood","year":"2014","unstructured":"A. Abood, P. Vestergaard, Pregnancy outcomes in women with primary hyperparathyroidism. Eur. J. Endocrinol. 171, 69\u201376 (2014)","journal-title":"Eur. J. Endocrinol."},{"key":"2615_CR41","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.jogc.2019.12.017","volume":"42","author":"G Cassir","year":"2020","unstructured":"G. Cassir, C. Sermer, A.K. Malinowski, Impact of perinatal primary hyperparathyroidism on maternal and fetal and neonatal outcomes: retrospective case series. J. Obstet. Gynaecol. Can. 42, 750\u2013756 (2020)","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"2615_CR42","doi-asserted-by":"crossref","unstructured":"G.E. Fuleihan, E. Brown, in Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism, ed. by J. Bilezikian, R. Marcus, C. Marcocci, S. Silverberg, J. Potts, The Parathyroids.3rd. (Elsevier, London, UK, 2015). pp. 365\u2013387","DOI":"10.1016\/B978-0-12-397166-1.00024-2"},{"key":"2615_CR43","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1210\/jc.2014-1414","volume":"99","author":"R Eastell","year":"2014","unstructured":"R. Eastell, M.L. Brandi, A.G. Costa, P. D\u2019Amour, D.M. Shoback, R.V. Thakker, Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J. Clin. Endocrinol. Metab. 99, 3570\u20133579 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2615_CR44","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/MED.0b013e32834c3c7c","volume":"18","author":"SE Christensen","year":"2011","unstructured":"S.E. Christensen, P.H. Nissen, P. Vestergaard, L. Mosekilde, Familial hypocalciuric hypercalcaemia: a review. Curr. Opin. Endocrinol. Diabetes Obes. 18, 359\u2013370 (2011)","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"2615_CR45","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.ecl.2011.08.002","volume":"40","author":"CS Kovacs","year":"2011","unstructured":"C.S. Kovacs, Calcium and bone metabolism disorders during pregnancy and lactation. Endocrinol. Metab. Clin. North Am. 40, 795\u2013826 (2011)","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"2615_CR46","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1515\/JPEM.2009.22.8.741","volume":"22","author":"C Horjus","year":"2009","unstructured":"C. Horjus, I. Groot, D. Telting, P. van Setten, A. van Sorge, C.S. Kovacs, A. Hermus, H. de Boer, Cinacalcet for hyperparathyroidism in pregnancy and puerperium. J. Pediatr. Endocrinol. Metab. 22, 741\u2013749 (2009)","journal-title":"J. Pediatr. Endocrinol. Metab."}],"updated-by":[{"DOI":"10.1007\/s12020-021-02899-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T00:00:00Z","timestamp":1634169600000}}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02615-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-021-02615-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02615-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T03:22:43Z","timestamp":1635823363000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-021-02615-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,5]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["2615"],"URL":"https:\/\/doi.org\/10.1007\/s12020-021-02615-2","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,5]]},"assertion":[{"value":"24 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12020-021-02899-4","URL":"https:\/\/doi.org\/10.1007\/s12020-021-02899-4","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}